1 / 13

USRDS 1999

Point Prevalence Counts by Modality, Data Source, and Year, 1988-97. USRDS/FS. Count (1000s). 191.9/199.7. Facility Survey (FS) USRDS Database. Center Hemo. 86.4. Functioning Transplant. PD. 26.7/30.0. Home Hemo. 1.7/1.9. *. III-1. Year. * Preliminary. USRDS 1999.

randi
Download Presentation

USRDS 1999

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Point Prevalence Counts by Modality,Data Source, and Year, 1988-97 USRDS/FS Count (1000s) 191.9/199.7 Facility Survey (FS) USRDS Database Center Hemo 86.4 Functioning Transplant PD 26.7/30.0 Home Hemo 1.7/1.9 * III-1 Year * Preliminary USRDS 1999

  2. Distribution of Point Prevalent ESRD Patients by Treatment Modality and Year, 1988-97 ESRD Patients (%) Center Hemo 62.3% Functioning Transplant 28.1% PD 8.7% 0.6% Home Hemo * III-2 Year * Preliminary USRDS 1999

  3. Distribution of Point Prevalent Dialysis Patients on December 31 by Year*, 1988-97 Dialysis Patients (%) CAPD 7.6% CCPD 4.4% Unspecified Dialysis 0.8% Home Hemo 0.7% ** Year *Center Hemodialysis (not shown) = 80-84% ** Preliminary III-3 USRDS 1999

  4. Patients on Waiting List for Kidney Transplant and Cadaveric Donor Transplants by Year, 1988-97 Transplants or Patients Awaiting Transplant (1000s) 36,036 On Waiting List Cadaveric Donor Transplants 8,479 Year III-4 USRDS 1999

  5. Transplants by Donor Source and Year, 1989-97 Transplants (1000s) Cadaveric 8,523 Living Related 3,217 Living Unrelated 705 * Year III-5 USRDS 1999 * Preliminary

  6. Dialysis Modality by Race, 1997 * Prevalent Patients (%) Remainder due to Home HD and Uncertain Dialysis III-6 Race * Preliminary USRDS 1999

  7. Dialysis Modality by Age, 1997* Prevalent Patients (%) Remainder due to Home HD and Uncertain Dialysis Age III-7 * Preliminary USRDS 1999

  8. Delivered Dialysis Dose* for Hemodialysis Patients by Year, 1986-97 Kt/V (Delivered) INC INC PREV INC PREV INC PREV USRDS Special Study Year(s) *Daugirdas corrected Kt/V III-8 **Source: HCFA 1998 ESRD Core Indicators Report; average of 1996 and 1997 USRDS 1999

  9. Average Urea Reduction Ratio (URR) by Year*, 1993-97 URR (%) Year III-9 *Source: HCFA 1998 ESRD Core Indicators Report USRDS 1999

  10. Average Weekly Kt/V Urea and Creatinine Clearance for CAPD Patients, by Year, 1995-98 Average Weekly Kt/V Urea* Average Weekly C. Creat.*† Year † (L/week/1.73m2) * Source: HCFA 1998 ESRD Core Indicators Report III-10 USRDS 1999

  11. 100 80 Modified Cellulose 60 40 20 0 Dialysis Membrane Type Used for Incident HD Patients by Year, 1990-97 Incident HD Patients (%) 14 2 2 16 67 32 27 4 16 21 HF Synthetic LF LF HF Cellulose DMMS W-1 DMMS W-2 CMAS Patients with missing membrane type are excluded. III-11 USRDS Special Study Year(s) USRDS 1999

  12. 100 80 60 40 20 0 Membrane Type* by Census Region, 1996-97 Incident HD Patients (%) * On about day 60 of ESRD from DMMS Wave 2 III-12 Census Region USRDS 1999

  13. 1989 90 91 92 93 94 95 96 1997 Hematocrit in Hemodialysis Patients, 1989-97 Average Hematocrit (Vol. %) All Prevalent at Year End* Prevalent on EPO All Incident (Medical Evidence Form) Year III-13 *HCFA 1998 ESRD Core Indicators Report USRDS 1999

More Related